For 35 years, EY has been at the forefront of industry; providing analysis and insights in their global Beyond Borders Biotechnology report. For the past three years, the focus has turned to Texas, a burgeoning hub of innovation and technology. In their upcoming Texas report dive into a comprehensive exploration of the biotech landscape in the Lone Star State, uncovering the latest statistics, trends, and market insights that showcase why Texas is a thriving epicenter for biotech advancements. 

In addition to mapping out the current state of the industry, the session will delve into the future, exploring emerging technologies and growth opportunities on the horizon. Renowned speakers will share their unique perspectives on the challenges and opportunities that lie ahead for Texas, the 8th largest economy in the world.

Explore the key trends and pressing issues in cell and gene therapy today, with a focus on the readiness of Texas to support research and development in this transformative field. Gain insights into the latest scientific advancements, regulatory challenges, infrastructure needs, and hear expert takes on Texas' current capabilities, potential opportunities, and strategic initiatives to position the state as a leader in cell and gene therapy innovation.

BioNTX is proud to continue growing a legacy of showcasing Texas-based companies at the iC³ Life Science Summit and invites you to nominate a Rising Star— an exceptional company with no more than $100 million in funding or revenue, solving critical challenges in health, pharma, or biosciences. Rising Stars are change-makers and innovators recognized for remarkable achievements, groundbreaking technologies, products, and dedication to addressing the world's most daunting social and healthcare issues.

Learn from industry experts as they explore best-practices for overcoming fundraising obstacles in difficult financial climates and how markets and investors can be leveraged successfully to advance your innovation. Learn vital strategies for identifying and reaching high-probability investors, crafting compelling pitches, and structuring intelligent milestones in early-stages. Leave with actionable insights for securing investments and building investor confidence in a challenging environment.

BioNTX is proud to honor the life, memory, and contributions of Dr. Dennis K. Stone by annually awarding an individual who has significantly impacted or contributed to the development of the North Texas bioscience and pharmaceutical industry. As a talented scientist, Dr. Stone played a pivotal role in growing and advancing biotechnology commercialization at UT Southwestern Medical Center and across North Texas. His altruistic dedication to his research and role in fostering biotechnology innovation in the region is canon, and a legacy model for success. 

Covering 16 counties in North Texas, and driven by strategic partnerships with industry and regional stakeholders; collaborations among educational institutions and life science companies are fostering a highly skilled workforce. Explore how this large-scale effort underscores the value of a pipeline of trained talent is essential for driving innovation and growth. Hear from top voices how these initiatives have North Texas poised to become a leader in the biotech and healthcare industries, ensuring a robust and dynamic future for the region.